| Literature DB >> 26883234 |
Anna Pinto1, Omar Faiz1, Rachel Davis1, Alex Almoudaris1, Charles Vincent2.
Abstract
OBJECTIVE: Surgical complications may affect patients psychologically due to challenges such as prolonged recovery or long-lasting disability. Psychological distress could further delay patients' recovery as stress delays wound healing and compromises immunity. This review investigates whether surgical complications adversely affect patients' postoperative well-being and the duration of this impact.Entities:
Keywords: SURGERY
Mesh:
Year: 2016 PMID: 26883234 PMCID: PMC4762142 DOI: 10.1136/bmjopen-2014-007224
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1PRISMA diagram. SF, Short Form Health Survey; QOL, quality of life.
Key characteristics of gastrointestinal surgery studies (n=29)
| First author's name | Year | Country | Primary or Secondary aim | Sample (N=number of patients in analysis/eligible patients, Nt(i)=sample size per time point, Nc=patients with complications, N1=cases vs N2=controls) | Patient inclusion criteria | Study design | Type of surgery | Surgical complications/method of recording | Psychosocial outcome/time points/measurement tool | Significant association of surgical complications with patients’ well-being (yes/no/confounding) | Types of complications and time points of significant effects | Quality assessment score (out of 8) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anthony | 2003 | US | Secondary | Nt1=71/? | Colorectal cancer, male patients who underwent open surgical therapy | Observational, cohort, prospective | Open surgical therapy for colorectal cancer | QoL/at time of diagnosis and 12 months after surgery/FACT-C | Yes* | Any complications/12 months postsurgery | 6 | |
| Avery | 2006 | UK | Primary | N=139/162 | Patients with oesophageal or gastric cancer who underwent upper gastrointestinal surgical treatment | Observational, cross-sectional | Upper gastrointestinal surgical treatment for oesophageal or gastric cancer | A major complication was defined as reoperation, readmission to the high dependency or intensive care unit, readmission to the hospital within 30 days of operation, or death within 30 days of operation or later if the patient did not leave the hospital/method not specified | QOL/39.6 days after treatment (range 6–105)/EORTC QLQ-C30 | Yes | Any complications/39.6 days after treatment (range 6–105) | 5 |
| Bitzer | 2008 | Germany | Secondary | Nt1=151/205 | Patients undergoing cholecystectomy | Observational, cohort, prospective | Cholecystectomy | Retrospective list: any complaint, wound infection, seroma, pneumonia, other complaints/patient reports | QoL/14 days preoperative, 14 days postoperative, and 6 months postoperative/SF-36 | Yes* | Any complications/6 months postsurgery | 7 |
| Bloemen | 2009 | The Netherlands | Primary | N=121/170 | Patients with rectal cancer | Observational, cross-sectional | Surgical treatment for adenocarcinoma of the rectum | Only severe complications were considered: grade III or IV complications (according to Dindo's model) were defined as severe, whereas absence of complications or grade I and II complications were defined as absent or mild complications/patient records | QoL/36 (16–51) months postoperative/EORTC QLQ-C30 and CR38 | Yes | Severe postoperative complications/median of 36 (range 16–51) months postsurgery | 6 |
| Bruns | 2010 | Germany | Secondary | N=96/188 | Patients who underwent curative hepatic resection for malignant or non-malignant diseases, disease free at time of assessment | Observational, cross-sectional | Hepatectomy | Surgical (eg, bile leak or biloma, pneumothorax, wound infection, liver abscess, bleeding, and surgical dehiscence) and medical (eg, pleural effusion, renal failure, hepatic failure, pneumonia, cardiac insufficiency and cholangitis)/patient records | QoL/ 3–36 months postoperative /SF-12 | Yes | Wound infections/3–36 months postsurgery | 5 |
| Champault | 2006 | France | Secondary | Nt1=152/? | Consecutive patients operated on for morbid obesity | Observational, cohort, prospective | Laparoscopic placement of a gastric band | Retrospective list: pulmonary atelectasis or pneumonia, prolonged ileus, minor wounds problems and urinary retention. Slippage with a peak incidence during the second postoperative year. Band erosion with penetration into the stomach. Access port problems (infection, haematoma, leak, disconnection), bands explanted, associated with erosion, obstruction, immediate intolerance and recurrent tubing break/method not specified | QoL/preoperative, 1, 3 months and 2 years postoperative/GIQLI | Confounding* | Band removal for complications such as erosion, slippage, intolerance/2-year postsurgery | 6 |
| Chang | 2010 | Taiwan | Secondary | N=102/218 | Patients undergoing bariatric surgery. | Observational, case–control, longitudinal | Roux-en-Y bypass | Operation-related complications, including gastrojejunal anastomotic stricture, gastrojejunal anastomotic ulcer, upper gastrointestinal bleeding and Gastro-oesophageal reflux disease (GORD)/method not specified | QoL/preoperative, 1, 3, 6 and 12 months postoperative/WHOQoL-BREF | Yes* | Any complications/1, 3, 6, 12 months postsurgery | 5 |
| Dasgupta | 2008 | UK | Secondary | Nt1=102/122 | Consecutive, patients undergoing liver surgery for liver cancer | Observational, prospective, cohort | Liver resection for hepatic malignancies | Major complications were defined as those associated with systemic illness requiring transfer to a higher level of care (high dependency or intensive care unit) or requiring relaparotomy, or complications needing interventional radiology/method not specified | QoL/preoperative, 6, 12, 36–48 months postoperative/EORTC QLQ-C30 | No* | NA | 6 |
| Delaney | 2003 | USA | Secondary | Nt1=109/109 | Patients with Crohn's disease | Observational, cohort, prospective | Surgery for CD (abdominal perineal, loop or end stoma) | Retrospectively listed complications: anastomotic leak, intra-abdominal abscess, bleeding, venous thrombosis, renal failure, and pneumonia, dehydration, intra-abdominal abscess, small bowel obstruction and wound infection/database review | QoL/preoperative and 30 days postoperative/CGQL | Yes* | Any complications/30 days postoperative | 7 |
| Douma | 2011 | The Netherlands | Secondary | N=296/? | 296 patients with FAP who had been surgically treated | Observational, cross-sectional | Surgery for FAP | Surgery-related complications/self-reports+medical records | QoL/0 to >10 years postoperative/SF-36, EORTC-QLQ-C38,Social Functioning subscale of the Dutch version of IBDQ | Yes | Any complications/0 to >10 years postsurgery | 2 |
| Dubernard | 2006 | France | Secondary | Nt1=58/? | Women with colorectal endometriosis who underwent a segmental colorectal resection | Observational, cohort, prospective | Laparoscopic segmental colorectal resection for endometriosis | Retrospectively listed complications: rectovaginal fistulae, vessel injury of the protective colostomy treated by laparoscopic coagulation, uroperitoneum requiring a ureteral stent for 6 weeks and an abscess behind colorectal anastomosis requiring a laparoscopic drainage/patient observations | QoL/preoperative and postoperative/SF-36 | No* | NA | 6 |
| El-Awady | 2009 | Egypt | Secondary | N=40/? | Patients with inguinal hernia | Observational, prospective, cohort | Anterior open Lichtenstein tension-free hernioplasty | Postoperative complications: seroma, haematoma, secondary infection, neuralgia and anaesthesia/patient observations | QoL/preoperative, 3, 6 and 12 months postoperative/SF-36 | No | NA | 4 |
| Hawn | 2006 | USA | Primary | Nt1=1983/3518 | Men who received a hernia repair | Observational, cohort, prospective | Inguinal herniorrhaphy | Complications were summarised by 4 categories: (1) haematoma/seroma, (2) orchitis, (3) neuralgia of the leg or groin, and (4) other. complications classified as ‘other’ included (1) early postoperative complications (urinary tract infection, urinary retention, and haematuria); (2) life-threatening complications (respiratory insufficiency, myocardial ischaemia, cardiac arrhythmia, intraoperative hypotension and stroke); and (3) long-term complications (4 weeks or more postoperative)/patient reports for neuralgia and orchitis + expert consensus for life-threatening complications | QOL/pre-op, 1 &2 years post-op/SF-36 | Yes* | Neuralgia, orchitis/2 years postsurgery | 8 |
| Ince | 2011 | USA | Secondary | Nt1=?/568 | Patients who underwent colorectal resection for benign and malignant diseases. | Observational, cohort, retrospective | Laparoscopic colorectal resection | No reference | QOL/pre-op, 4 weeks post-op/SF-36 | No* | NA | 3 |
| Kalliomaki | 2009 | Sweden | Primary | N(total)=184/423 | Patients who had been operated on for groin hernia. Controls matched for age, gender and method of surgical repair were allotted from the group of persons without persisting pain (grade 1 in IPQ) | Observational, case–control, cross-sectional | Hernia repair | Persistent postoperative pain (patients with pain of grade 3, ie, pain that could not be ignored but did not interfere with everyday activities, or higher on IPQ)/patient reports (IPQ) and clinical examination | QoL, anxiety, depression/(on average 4.9 years postoperative, range > 7 years)/SF-36, HADS | Yes | Persistent postoperative/mean of 4.9 years postsurgery | 5 |
| Kement | 2011 | Turkey | Primary | N=253/351 | Consecutive patients with chronic anal fissure who underwent open lateral internal sphincterotomy (LIS). | Observational, cross-sectional | Open lateral internal sphincterotomy | Anal incontinence/patient reports: WIS system + clinical examination | QoL/23.3±7.1 months postoperative/SF-36 | Yes | Severe incontinence/23.3 (SD±7.1) months postsurgery | 5 |
| Lim | 2006 | UK | Primary | N=92/112 | Consecutive patients under the care of three consultant surgeons who underwent procedures with LRA | Observational, cross-sectional | LRA | Anastomotic leaks (clinical and subclinical)/patient observations, CT scans, Wireless Capsule Endoscopy (WCE) | QoL/10–18 months postoperative/EORTC QoL | Confounding | Anastomotic leaks/10–18 months postoperative | 5 |
| Liu | 2010 | US | Primary | N=679/1308 | Patients with long-term colorectal cancer | Observational, cross-sectional | Colorectal cancer surgery | Digestive, skin, genitourinary, surgical, medical, immediate indirect complicationsEarly complications: those that were first recorded within 30 days of the surgery. Late complications: occurring 31 days after surgery/patient computerised data | QoL/ 5–15 years postoperative/modified City of Hope (mCOH)-QoL-Ostomy | Yes | Enterocutaneous fistula for all patients and any late complications for ostomy patients >5 years postsurgery | 6 |
| Mentes | 2006 | Turkey | Primary | Nt1=253/302 | Patients who underwent lateral internal sphincterotomy (LIS) for CAF | Observational, cohort, prospective | Lateral internal sphincterotomy (LIS) for CAF | Anal incontinence/atient examination+ FISI score | QoL/preoperative (admission) and 12 months postoperative/GIQLI and FIQL | Unclear (due to small number of patients with complications) | NA | 6 |
| Pittman | 2008 | USA | Primary | N=239/322 | Veterans with an ostomy after major gastrointestinal surgery requiring an intestinal stoma | Observational, case–control, cross-sectional | Gastrointestinal surgery requiring an intestinal stoma | Ostomy complications: skin problems, leakage and difficulty with adjustment (ie, leakage, peristomal irritant dermitis, pain, bleeding, stomal necrosis, prolapse, stenosis, herniation, retraction, infection, mucotaneous separation, difficulty adjusting)/patient reports | QoL/6 months postoperative/mCOH-QoL-Ostomy | Yes | Ostomy complications (skin problems, leakage)/ 6 months postsurgery | 6 |
| Polese | 2012 | Italy | Primary | N=147/211 | Patients who underwent elective left colonic or rectal resection and colorectal anastomosis for neoplastic or inflammatory disease | Observational, cross-sectional | Left colonic or rectal resection and colorectal anastomosis | Anastomotic stenosis/clinical examination | QoL/mean 58 (SD±31) months postoperative/SF-36 | Yes | Anastomotic stenosis/58 (SD±31) months postsurgery | 6 |
| Rea | 2007 | USA | Primary | Nt1=505/? | Patients who underwent Roux-en-Y gastric bypass (LRYGB) by one surgeon for morbid obesity | Observational, cohort, prospective | LRYGB for morbid obesity without conversion to an open procedure | Postoperative complications requiring intervention/method not specified | QoL/baseline, 1 and 2 years postoperative/SF-36 | Yes* | Complications requiring intervention/1 and 2 years postsurgery | 6 |
| Riss | 2011 | Austria | Primary | N1=16/36 (cases) | Cases: patients operated for rectal cancer and developed anastomotic leak. Controls: patients operated for rectal cancer at the same time period and had an uneventful postoperative course matched by sex, age (±5 years), type of resection, and neoadjuvant therapy | Observational, case–control, cross-sectional | Rectal resection for malignancies on overall pelvic organ function | Anastomotic leakage: defined as grade A (no change in patient's management), grade B (requires active therapeutic intervention but is managed without relaparotomy) and grade C (requires relaparotomy)/review of the institutional colorectal database and individual chart reviews | QoL/106.8 months postoperative (32.4–170.4)/SF-12 | No | NA | 7 |
| Rutegard | 2008 | Sweden | Secondary | N=355/446 (79·6%) | Patients diagnosed with an | Observational, cross-sectional | Oesophageal resection | Technical surgical complications, including postoperative bleed exceeding 2000 ml or requiring a reoperation, anastomotic insufficiency, necrosis of the substitute, damage to the recurrent nerve, thoracic duct damage or gastric perforation/prospective scrutiny of medical and histopathological records, operation charts, extensive study protocol with predefined exposure alternatives | QoL/6 months postoperative/EORT QLQ-C30, and QLQ-OES1812 | Yes | Technical complications/6 months postsurgery | 7 |
| Scarpa | 2009 | Italy | Secondary | N=47/? | Patients admitted for intestinal surgery for Crohn's disease | Observational, cross-sectional | Bowel resection through midline laparotomy or with laparoscopic assistance, end ileostomy, stricturoplasty | Medical and surgical complications and need of reoperation (2 anastomotic leaks, 3 intestinal obstructions, 2 intestinal bleeding, and a wound infection were recorded and two relaparotomies)/method not specified | QoL/3 months postoperative/CGQLI | Confounding | Any complications/3 months postsurgery | 3 |
| Sharma | 2007 | UK | Secondary | Nt1=104/110 | Consecutive patients with newly diagnosed colorectal | Observational, cohort, prospective | Elective resection | Wound, urinary tract and chest infections, cardiac and respiratory complications, deep venous thrombosis, pulmonary embolism and complications related to anastomotic breakdown/method not specified | QoL, anxiety, depression, positive vs negative affectivity, mood states/preoperative (5–12 days preoperative) and 6–8 weeks postoperative/FACT-C, EuroQOL (EQ-5D), HADS, PANAS, MRS | Yes* | Complications within 30 days of operation/6–8 weeks postsurgery | 6 |
| Siassi | 2009 | Germany | Secondary | Nt1=93/113 | Patients undergoing colorectal surgery for benign and malignant | Observational, prospective, cohort | Resection of the sigmoid | Postoperative complications (anastomotic leak, wound infection, delayed food intake, fever, and bladder dysfunction)/method not specified | QoL/preoperative, 3 and 12 months postoperative/SF-36 and GLQI | Yes* | Any complications/3 months postsurgery | 7 |
| Targarona | 2004 | Spain | Primary | N=37/46 | Patients diagnosed with paraoesophageal or mixed hiatal hernia (types II, III and IV) with >50% of the stomach in the chest | Observational, cross-sectional | Laparoscopic repair of paraoesophageal hiatal hernia | Hernia recurrence (any migration of the cardia to chest level or evidence of a new paraoesophageal sac)/a barium swallow was given to all patients to rule out an anatomic recurrence. An independent radiologist evaluated all the explorations | QoL/≥6 months postoperative (median, 24; range, 6–50)/SF-36, GDSS and GIQLI | Yes | Clinically recurrent hernias/≥6 months postsurgery | 5 |
| Viklund | 2005 | Sweden | Secondary | N=100/146 | Patients newly diagnosed with a histologically verified adenocarcinoma or squamous-cell carcinoma of the oesophagus or adenocarcinoma of the gastric cardia that underwent macroscopically and microscopically radical tumour resection | Observational, cross-sectional | Oesophageal resection surgery for cancer | Anastomotic leakage, infections, respiratory insufficiency, cardiac complications, technical complications, anastomotic strictures, and others (intervention needed to treat embolus, deep venous thrombosis, rupture of the wound, intestinal obstruction, stroke, renal failure, or liver failure)/patient records | QoL/6 months postdischarge/QLQ-C30 and OES-24 | Yes | Any complications, anastomotic leakage, infection, respiratory insufficiency, cardiac complications, technical complications/6 months postdischarge | 7 |
Symptoms specific to oesophageal cancer.
*Study controlled for patients’ preoperative well-being.
CAF, chronic anal fissure; CGQL, Cleveland Global Quality of Life; COH-QoL Ostomy, City of Hope Quality of Life for Ostomates questionnaire; EORTC, European Organisation for Research and Treatment of Cancer core; EORTC, European Organisation for Research and Treatment of colorectal cancer; FACT-C, Functional Assessment of Cancer Therapy questionnaire with the colorectal module; FAP, familial adenomatous polyposis; FIQL, Fecal Incontinence Quality of Life Instrument; GDSS, Glasgow Dyspepsia Severity Score; GIQLI, Gastrointestinal Quality of Life Index; GLQI, Gastrointestinal Quality of Life Index; HADS, Hospital Anxiety and Depression Scale; IBDQ, Inflammatory Bowel Disease Questionnaire; IPQ, Inguinal Pain Questionnaire; LRA, low rectal anastomosis; MRS, Mood Rating Scale; NA, not available; OES, Oesophageal Cancer-Specific questionnaire; PANAS, positive and negative affect schedule; SF, Short Form Health Survey; WHOQoL BREF, WHO Quality of Life—Brief; WIS, Wexner Incontinence Score.
Key characteristics of cardio-thoracic surgery studies (n=17)
| First author name | Year | Country | Primary or secondary aim | Sample (N=number of patients in analysis/eligible patients, Nt(i)=sample size per time point, Nc=patients with complications, N1=cases vs N2=controls) | Patient inclusion criteria | Study design | Type of surgery | Surgical complications/method of recording | Psychosocial outcome/time points/measurement tool | Significant association of complications with well-being (yes/no/confounding) | Types of complications and time points of significant effects | Quality assessment score (out of 8) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deaton | 2009 | USA | Secondary | Nt1=317/442 | Patients with documented T2DM undergoing CABG | Observational, cohort, prospective | CABG | Infection of the leg, thorax, sternum, bloodstream or urinary tract; central neurological deficit (stroke or transient ischemia, coma); pneumonia, pulmonary insufficiency with prolonged ventilation or reintubation, pulmonary embolism; renal failure; arrhythmias requiring treatment; prolonged inotropic support or use of intra-aortic balloon pump; or reoperation for bleeding or tamponade/patient records | QoL/3 months post-op/SF-36 | Yes | Any complications/3 months postsurgery | 6 |
| El Baz | 2008 | The Netherlands | Secondary | Nt1=198/256 | Consecutive patients who were scheduled for CABG following a coronary angiography | Observational, cohort, prospective | CABG | Postoperative events such as use of inotropes, atrial arrhythmias, or ventricular arrhythmias, sternal resuturing, re-exploration for bleeding, and time spent on mechanical ventilation/registry database, medical notes, outpatient notes and intensive therapy unit charts | QoL/preoperative and 6 months postoperative/SF-36 | Yes* | Re-exploration for bleeding and sternal resuturing/6 months postsurgery | 8 |
| Ferguson | 2009 | USA | Primary | N=124/221 | Prospective patients who underwent major lung resection for early stage lung cancer. | Observational, cross-sectional | Major lung resection for early stage lung cancer (lobectomy, bilobectomy, pneumonectomy) | Complications were categorised as pulmonary (pneumonia, prolonged intubation, reintubation, air leak more than 7 days, lobar collapse requiring intervention), cardiovascular (pulmonary embolism, myocardial infarction, new postoperative arrhythmia, need for intravenous inotropic agents), other, and any complication/administrative database, hospital medical records, office shadow files | QoL/average of 2.6 years postoperative (3 months to 6.4 years)/EORTC QLQ-C30, EORTC QLQLC13 and DASS-21 | Yes | Pulmonary complications/2.6 years postsurgery (range 3 months to 6.4 years) | 6 |
| Gjeilo | 2010 | Norway | Primary | Nt1=534/631 | Patients undergoing cardiac surgery | Observational, cohort, prospective | Midline | Chronic pain (pain arising after surgery and persisting either continuously or intermittently for 3 months or more/BPI | QoL/preoperative, 6 and 12 months postoperative/SF-36 | Yes* | Chronic postsurgical pain/12 months postsurgery | 6 |
| Hata | 2006 | Japan | Secondary | N=452/452 | Consecutive adult patients who underwent open heart surgery | Observational, cross-sectional | CABG | Postoperative morbidity (minor stroke, infection, pneumonia, haemodialysis, paraplesis)/patient records | Depression/5–7 days postopertive/interviewed by a psychiatrist and CES-D | Confounding | Postoperative minor stroke and pneumonia/5–7 days postsurgery | 6 |
| Jarvinen | 2004 | Finland | Primary | Nt1=501/1128 | Patients who underwent CABG | Observational, cohort, prospective | CABG (89% via sternotomy incision with | Perioperative myocardial infarctions/clinical examination + clinical tests (ECGs, echocardiography, laboratory tests) | QoL/preoperative and 12 months postoperative/RAND-36 | Yes* | Perioperative myocardial infarctions /12 months postsurgery | 7 |
| Jideus | 2009 | Sweden | Primary | N1=73/84 (cases) |
Cases: patients who developed SWI after cardiopulmonary bypass Controls: patients prior to CABG and evaluated 1 year postoperative and matched for time of the operation, age and sex | Observational, case–control, cross-sectional | Cardiopulmonary bypass | SWIs: deep infection involving retrosternal tissue and/or the sternal bone)/clinical examination | QoL/20 months postoperative (range 7–40)/SF-36 | Yes* | Serious wound infections/20 (range 7–40) months postsurgery | 4 |
| Kinney | 2012 | USA | Primary | N=99 | Patients aged 45–75 years undergoing elective thoracotomy | Observational, cohort, prospective | Serratus-sparing | Chronic post-thoracotomy pain/Leeds Assessment of Neuropathic Symptoms and Signs + self-reports | QoL/preoperative, 3 months postoperative/SF-36 | Yes* | Chronic post-thoracotomy pain/3 months postsurgery | 7 |
| Landoni | 2006 | Italy | Primary | N1=22/42 (cases) | Cases: patients who underwent cardiac surgery and developed ARF requiring RRT and left the hospital aliveControls: matched controls who did not develop ARF and did not receive RRT | Observational, case–control, cross-sectional | Cardiac surgery (procedures not specified) | ARF requiring RRT/administrative database, registry | QoL/23–42 months post-op/SF-36 | No | NA | 6 |
| Le Grande | 2006 | Australia | Secondary | Nt1=182/444 | Adults on the waiting list for CABG | Observational, cohort, prospective | CABG | Postsurgical complications such as cardiac arrhythmias, stroke and infections/medical records | QoL/preoperative, 2 and 6 months postoperative/SF-36 | Yes* | New cardiac arrhythmia postsurgery, atrial fibrillation/6 months postsurgery | 7 |
| Martin | 2008 | USA | Primary | Nt1=836/2,007 | Patients undergoing elective open heart surgery | Observational, cohort, prospective | Open heart surgery (133 valve procedure; 620 CABG; 67 CABG plus valve procedure; 15 CABG plus other cardiac procedure; and 1 closure of an atrial septal defect) | Perioperative myocardial infarction, mediastinitis, superficial wound infection, septicaemia, permanent stroke, transient ischaemic attack, continuous coma, prolonged intubation, ventilator-associated pneumonia, cardiac tamponade, atrial fibrillation, reoperation for bleeding, renal failure, renal failure which required dialysis, and length of stay/method not specified | QoL/preopeative, 1 year postopeative/SF-20 | No* | NA | 6 |
| Merkouris | 2009 | Greece | Secondary | Nt1=63/63 | All patients over 65 presenting a 1, 2 or 3 vessel disease treated with CABG without concurrent procedures (eg, valve replacement) | Observational, cohort, prospective | CABG | Retrospective list of complications: atrial fibrillation, re-exploration for bleeding, low cardiac output syndrome, acute respiratory failure, sternal wound infection, neurological dysfunction, mild problems related to leg incision healing or swelling, chest incision discomfort and medications/method not specified | QoL/preopeative, 4 and 12 months postopeative/MacNew Heart Disease HRQoL questionnaire | No* | NA | 5 |
| Moller | 2012 | Sweden | Secondary | Nt1=249/? | Prospective patients scheduled for lung surgery for lung cancer | Observational, cohort, prospective | Lung surgery | Complication was defined as any of the following postoperative complications: new onset atrial fibrillation, prolonged air leak (chest tubes in place for more than 5 days), pneumonia, reintubation, reoperation, or hospital stay of 8 days or more/method not specified | QoL/preoperative, 6 months postoperative/SF-36 | Yes* | Any complications/6 months postsurgery | 6 |
| Myles | 2001 and 2006 | Australia | Secondary | Nt1=120/125 | Adult cardiac surgical patients | Observational, cohort, prospective | Cardiac surgery (specific procedures not specified) |
Respiratory: postoperative mechanical ventilation for more than 24 h or pneumonia, defined as pulmonary infiltrate with positive microbial cultures Cardiac: arrhythmia requiring treatment with antiarrhythmic medication or electrical cardioversion reversion; radiological evidence of pulmonary oedema; or myocardial infarction, defined by new Q waves on ECG or creatine kinase-MB isoenzyme concentration greater than twice normal Renal: acute renal failure, defined by serum creatinine concentration greater than 200 M Neurological: stroke, defined as a new central neurological deficit Sepsis: wound infection requiring excision of tissue or antibiotic therapy, or positive microbial culture (other than pneumonia)
Clinical and laboratory tests (microbial cultures, radiological data, ECGs, etc) | QoL/preoperative, 1 and 3 months, 3 years postoperative/SF-36 | Confounding* | Any complications/3 months postsurgery | 8 |
| Peric | 2008 | Serbia and Montenegro | Secondary | Nt1=208/? | Consecutive patients who underwent elective CABG | Observational, cohort, prospective | CABG | Retrospective list of complications: low cardiac output (cardiac index lower than 2 L/min/m2), mechanical ventilation longer than 24 h, reoperation for bleeding, sternal wound infection, perioperative myocardial infarction, pericardial effusion, arrhythmic complications (atrial fibrillation, ventricular tachycardia, ventricular fibrillation), abdominal complications, and other/observations, ECGs, echocardiography, laboratory tests | QoL/preoperative, 6 months postoperative/NHP Questionnaire | Yes* | Any complications/6 months postsurgery | 7 |
| Rodriguez | 2008 | USA | Secondary | Nt1=397/? | Patients diagnosed with upper extremity hyperhidrosis (HH) treated with thoracic sympathectomy (TS) | Observational, cohort, prospective | Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis |
CS: excessive sweating considered abnormal in other parts of the body after TS Gustatory sweating: facial sweating after eating foods Excessive dryness: dryness affecting the hands and requiring hydration Method not specified | QoL/preoperative, discharge, 6 and 12 months postoperative/SF-36 | No* | NA | 3 |
| Tully | 2011 | Australia | Primary | Nt1=226/238 | Patients undergoing first-time CABG surgery | Observational, cohort, prospective | CABG | New-onset AF between the patient's day of admission to the intensive care unit and the median day of discharge (day 5) after CABG during the index hospitalisation/ECGs, transthoracic echocardiographs reviewed by technicians and reviewers blinded to patients’ psychological distress scores | Anxiety, depression, stress/preoperative (mean=2 days, SD=2 days) and postoperative (mean=6 days, SD=2 days)/ DASS | Yes* | Atrial fibrillation/6 days (SD=2 days) postsurgery | 7 |
*Study controlled for patients’ preoperative well-being.
ARF, acute renal failure; AF, atrial fibrillation; BPI, Brief Pain Inventory; CES-D, Center for Epidemiological Studies Depression Scale; CS, compensatory sweating; DASS, Depression Anxiety Stress Scales; DASS, Short version of the Depression Anxiety Stress Scales; EORTC QLQLC, European Organisation for Research and Treatment of Cancer core Lung Cancer Questionnaire; HRQoL, health-related quality of life; NA, not available; NHP, Nottingham Health Profile; QoL, quality of life; RRT, renal replacement therapy; SF, Short Form Health Survey; SWI, sternal wound infection; T2DM, type 2 diabetes mellitus.
Key characteristics of studies in vascular surgery (n=4)
| First author name | Year | Country | Primary or secondary aim | Sample (N=number of patients in analysis/eligible patients, Nt(i)=sample size per time point, Nc=patients with complications, N1=cases vs N2=controls) | Patient inclusion criteria | Study design | Type of surgery | Surgical complications/method of recording | Psychosocial outcome and time points | Significant association of complications with well-being (Yes/No/Confounding) | Types of complications and time-points of significant effects | Quality assessment score (out of 8) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lohse | 2009 | Germany | Secondary | N=110/124 | Consecutive patients who received a replacement of the dilated ascending aorta | Observational, cross-sectional | Ascending aorta replacement | Retrospective list: postoperative bleeding, myocardial infarction, stroke, pneumonia, respiratory insufficiency, acute renal dysfunction, sepsis, lung fistula/method not specified | QoL/36.4±15.5 months postoperative (11–58 months)/SF-36 | NO | NA | |
| Nguyena | 2007 | USA and Canada | Primary | Nt1=1296/1404 | Patients who underwent lower extremity vein bypass for CLI in community and university hospitals across the US and Canada | Observational, cohort, prospective | Lower extremity vein bypass for limb salvage in CLI patients | Wound complications (WC): patients having infection, necrosis, hematoma-haemorrhage, or seroma-lymphocele at the surgical incision or harvest site within 30 days of the bypass surgery/Adverse events clinical trial documentation with reference to source documentation (hospital notes etc.) | QoL/baseline, 3 and 12 months postoperative/VascuQol | Confounding* | Wound complications/3 months postsurgery | |
| Nguyenb | 2006 | USA and Canada | Secondary | N1=1296/1404 (92.3%) | Patients who underwent IB for CLI in community and university hospitals across the USA and Canada | Observational, cohort, prospective | Infrainguinal vein grafting for limb salvage in patients with CLI | GREs: development of a >70% graft stenosis or having undergone a percutaneous or surgical revision or a major amputation/clinical tests (angiography, ultrasonography, etc), source documentation (hospital notes, discharge notes, operative and procedural notes, etc) | QoL/preoperative, 3 and 12 months postoperative/VascuQol | Yes* | GREs/12 months postsurgery | |
| Subramonia | 2005 | UK | Primary | Nt1=70/70 | Patients with varicose veins, either symptomatic or with skin changes, resulting from incompetence of the lesser saphenous vein system (LSV) as confirmed by handheld Doppler examination or duplex ultrasonography or both and requiring surgical intervention (both day cases and inpatients) | Observational, cohort, prospective | Conventional LSV stripping |
Bruising/tracing method Sensory abnormalities, both subjective (paraesthesia and dysaesthesia) and objective/patient reports, sensory testing | QoL/preoperative, discharge and 6 weeks postoperative/Aberdeen Varicose Vein Questionnaire 2 | No* | NA |
*Study controlled for patients’ preoperative well-being.
CLI, critical limb ischaemia; GRE, graft-related event; NA, not available; QoL, quality of life; VascuQol, a validated instrument assessing pain, symptoms, activities, social life and emotional state in patients with vascular disease.
Domains of patients’ well-being that were significantly affected by surgical complications
Continued
CGQL, Cleveland Global Quality of Life; DASS, Depression Anxiety Stress Scales; EORTC, European Organisation for Research and Treatment of Cancer; FACT-C, Functional Assessment of Cancer Therapy questionnaire with the colorectal module; GIQLI, Gastrointestinal Quality of Life Index; HADS, Hospital Anxiety and Depression Scale; IBDQ, Inflammatory Bowel Disease Questionnaire; MRS, Mood Rating Scale; NHP, Nottingham Health Profile; PANAS, positive and negative affect schedule; QoL, quality of life; VascuQoL, a validated instrument assessing pain, symptoms, activities, social life and emotional state in patients with vascular disease.